Alantra advises STADA on the sale of branded asset FR!SKA to Megalabs
SECTORHealthcare
ServiceM&A
Dec 2022
Sell-side advisory
New York – Alantra, a leading global investment bank and asset management firm, is pleased to announce that it has advised STADA, a pan-European pharmaceutical company, on the Sale of US branded asset FR!SKA to Megalabs, a Uruguay-based multinational pharmaceutical manufacturing and distributing company.
FR!SKA is the only “Probiotics + Enzyme” two-in-one digestive brand on the market. The brand was founded and led by Target veteran, John Peine.
The Alantra US Healthcare team advising STADA included Rusty Ray, Christian Carlson, PhD, Michaela Zhang and Darius Kuddo.
